BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 18000789)

  • 1. The role of hemostatic system inhibitors in malignancy.
    Wojtukiewicz MZ; Sierko E; Kisiel W
    Semin Thromb Hemost; 2007 Oct; 33(7):621-42. PubMed ID: 18000789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of platelet function: does it offer a chance of better cancer progression control?
    Sierko E; Wojtukiewicz MZ
    Semin Thromb Hemost; 2007 Oct; 33(7):712-21. PubMed ID: 18000800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin in tumor progression and metastatic dissemination.
    Falanga A; Marchetti M
    Semin Thromb Hemost; 2007 Oct; 33(7):688-94. PubMed ID: 18000796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of the hemostatic system to angiogenesis in cancer.
    Wojtukiewicz MZ; Sierko E; Rak J
    Semin Thromb Hemost; 2004 Feb; 30(1):5-20. PubMed ID: 15034794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemostatic abnormalities associated with cancer and its therapy.
    Glassman AB
    Ann Clin Lab Sci; 1997; 27(6):391-5. PubMed ID: 9433535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer and thromboembolism: from biology to clinics.
    Castelli R; Porro F
    Minerva Med; 2006 Apr; 97(2):175-89. PubMed ID: 16760856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venous thromboembolism in oncology.
    Falanga A; Vignoli A
    Eksp Onkol; 2004 Mar; 26(1):11-4. PubMed ID: 15112573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development and dissemination of malignant tumors and hemostasis].
    Kher A; Hilgard P
    Pathol Biol (Paris); 1982 Dec; 30(10):861-7. PubMed ID: 6760066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of tissue factor pathway inhibitor in tumor growth and metastasis.
    Amirkhosravi A; Meyer T; Amaya M; Davila M; Mousa SA; Robson T; Francis JL
    Semin Thromb Hemost; 2007 Oct; 33(7):643-52. PubMed ID: 18000790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemostasis and malignancy.
    Francis JL; Biggerstaff J; Amirkhosravi A
    Semin Thromb Hemost; 1998; 24(2):93-109. PubMed ID: 9579631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-induced alterations of hemostasis and fibrinolysis.
    Fareed J; Hoppenstedt D; Bick RL; Bacher P
    Hematol Oncol Clin North Am; 1992 Dec; 6(6):1229-45. PubMed ID: 1452510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemostatic complications of angiogenesis inhibitors in cancer patients.
    Elice F; Jacoub J; Rickles FR; Falanga A; Rodeghiero F
    Am J Hematol; 2008 Nov; 83(11):862-70. PubMed ID: 18819092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of blood coagulation inhibitors in colon cancer].
    Sierko E; Zawadzki RJ; Zimnoch L; Sulkowski S; Wojtukiewicz MZ
    Pol Merkur Lekarski; 2006 Apr; 20(118):462-7. PubMed ID: 16886577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein C and its inhibitor in malignancy.
    Suzuki K; Hayashi T
    Semin Thromb Hemost; 2007 Oct; 33(7):667-72. PubMed ID: 18000793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cancer, hemostasis and coaguloactive drugs].
    Nadiradze ISh
    Vopr Onkol; 1989; 35(12):1411-8. PubMed ID: 2692281
    [No Abstract]   [Full Text] [Related]  

  • 16. Clotting mechanisms and cancer: implications in thrombus formation and tumor progression.
    Falanga A; Marchetti M; Vignoli A; Balducci D
    Clin Adv Hematol Oncol; 2003 Nov; 1(11):673-8. PubMed ID: 16258469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the plasminogen activation system in cancer.
    Carroll VA; Binder BR
    Semin Thromb Hemost; 1999; 25(2):183-97. PubMed ID: 10357086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignancy as a solid-phase coagulopathy: implications for the etiology, pathogenesis, and treatment of cancer.
    Zacharski LR
    Semin Thromb Hemost; 2003 Jun; 29(3):239-46. PubMed ID: 12888928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemostatic and hemorrhagic problems in neurosurgical patients.
    Gerlach R; Krause M; Seifert V; Goerlinger K
    Acta Neurochir (Wien); 2009 Aug; 151(8):873-900; discussion 900. PubMed ID: 19557305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical studies with anticoagulants to improve survival in cancer patients.
    Gerotziafas GT; Papageorgiou C; Hatmi M; Samama MM; Elalamy I
    Pathophysiol Haemost Thromb; 2008; 36(3-4):204-11. PubMed ID: 19176993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.